PLD is upregulated in various cancers and implicated in tumor malignancy, maintenance of self‐renewal of cancer stem cells, and resistance to radiotherapy and chemotherapy (Brown, Thomas, & Lindsley, 2017; Cheol Son et al., 2013; Kang, Choi, & Min, 2014; Kang et al., 2015; Kang, Lee, Hwang, 2017). Here, GPLD1 is linked to cancer.